3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
54
Lung Neoplasms
46
Neoplasm Metastasis
36
Carcinoma, Non-Small-Cell Lung
36
Multiple Myeloma
26
Breast Neoplasms
26
Glioma
23
Carcinoma, Renal Cell
22
Pancreatic Neoplasms
21
Melanoma
21
Glioblastoma
21
Lymphoma, Large B-Cell, Diffuse
20
Squamous Cell Carcinoma of Head and Neck
19
Ovarian Neoplasms
19
Urinary Bladder Neoplasms
18
Lymphoma
18
Colorectal Neoplasms
18
Triple Negative Breast Neoplasms
15
Oropharyngeal Neoplasms
15
Mouth Neoplasms
15
Brain Neoplasms
15
Fallopian Tube Neoplasms
13
Carcinoma, Hepatocellular
13
Carcinoma
13
Laryngeal Neoplasms
12
Astrocytoma
12
Lymphoma, Follicular
11
Leukemia, Myeloid, Acute
11
Sarcoma
10
Neuroblastoma
10
Interventions
Cisplatin
14
Paclitaxel
12
pembrolizumab
9
Fluorouracil
7
Radiotherapy
6
Irinotecan
5
Esophagectomy
5
tislelizumab
4
Oxaliplatin
4
Leucovorin
4
Drug Therapy
4
Carboplatin
4
toripalimab
3
Levoleucovorin
3
Docetaxel
3
Capecitabine
3
camrelizumab
2
Taxes
2
Radiation
2
Nivolumab
2
Injections
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
sintilimab
1
palbociclib
1
nimotuzumab
1
nazartinib
1
lenvatinib
1
ivarmacitinib
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Magnetic Resonance Spectroscopy
×
90 days
×
Clear all
No trials found.